What did @better.research actually say?
The creator didn't make clinical claims here. They promoted a free peptide dosing calculator available on their website, saying users don't need an account and can find it in the menu tab. That's the whole claim: "we actually created this free peptide calculator that anyone can use." Short, promotional, and light on detail. There's no dosing advice given directly in this video, no compound named, no condition treated. Taken at face value, it's an advertisement for a tool, not a medical recommendation. But the context of that tool matters enormously, which is where this gets complicated.
Does the science back this up?
This is the wrong question for this particular video, because no scientific claim was made. The real question is whether a publicly accessible peptide dosing calculator, with no clinical gatekeeping, is appropriate or safe. The short answer is: not really. Peptides like BPC-157, TB-500, CJC-1295, and ipamorelin are not FDA-approved therapeutics. Their dosing windows in humans are not established by randomized controlled trials. Most data comes from rodent studies or anecdotal clinical reports. Sims et al. (2020, International Journal of Peptide Research and Therapeutics) noted that extrapolating rodent peptide dosing to humans lacks standardized methodology. A calculator built on that kind of foundation isn't evidence-based. It's math applied to guesswork.
What did they get wrong (or right)?
To be fair, the creator didn't say anything factually false. They didn't claim a peptide treats a disease. They didn't prescribe a dose on camera. The statement "anyone can use" it is technically accurate if the tool is publicly posted. But that phrase is actually the problem. Peptide dosing is not a one-size-fits-all calculation. Body weight, renal function, concurrent medications, reconstitution concentration, and injection site all affect how a peptide behaves. A free online calculator strips away every one of those variables. Providers at regulated telehealth platforms individualize these decisions for exactly that reason. Promoting open-access dosing tools for research chemicals to a general TikTok audience sidesteps the clinical layer that keeps people from making serious errors.
What should you actually know?
If you're curious about peptide therapy, the calculator isn't your starting point. The starting point is a licensed provider who can review your labs, your history, and your goals. Here's what a calculator can't account for:
- Whether a compound is appropriate for you at all
- How your individual physiology affects absorption and clearance
- Drug interactions with anything else you're taking
- The concentration of the specific vial you're reconstituting
- Whether your source is actually what it claims to be
Compounded peptides in the U.S. exist in a regulatory gray zone. The FDA has issued warnings about certain compounded peptides, including BPC-157, flagging them as not meeting the criteria for compounding under federal law. Using a dosing calculator doesn't change that regulatory reality. Free tools that simplify complex clinical decisions can give users false confidence. That's not a hypothetical risk. It's the mechanism behind most self-administration errors.
Is there a version of this that's done responsibly?
Yes. Dosing calculators can be legitimate clinical aids when they're used inside a supervised care model, not as a replacement for one. Platforms that use calculators internally, as a support tool for providers ordering therapy, are using them appropriately. A calculator that patients access independently, before any clinical intake, inverts that model. The tool becomes the provider. If @better.research's calculator is embedded in a supervised clinical workflow, that context was entirely absent from this video. And in a 15,000-view TikTok post, that missing context is not a minor omission.